Showing results (1-10 of 527) with videos related to
Sort By:
Pageof 53
Parkinsonism & Related Disorders|November 23, 2013
Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?Brit MollenhauerMovement Disorders : Official Journal of the Movement Disorder Society|April 18, 2012
Biochemical premotor biomarkers for Parkinson's diseaseBrit Mollenhauer, Jing ZhangMovement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Neurochemical biomarkers in the differential diagnosis of movement disordersBrit Mollenhauer, Claudia TrenkwalderMethods in Molecular Biology (Clifton, N.J.)|February 17, 2019
Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based DetectionNiels Kruse, Brit MollenhauerAlzheimer'S Research & Therapy|December 6, 2014
Biomarkers in biological fluids for dementia with Lewy bodiesSebastian Schade, Brit MollenhauerJournal of Immunological Methods|August 15, 2015
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluidNiels Kruse, Brit MollenhauerInternational Review of Neurobiology|May 31, 2017
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's DiseaseIskandar Johar, Brit Mollenhauer, Dag AarslandMovement Disorders : Official Journal of the Movement Disorder Society|April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical PracticeTiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.Science (New York, N.Y.)|August 18, 2022
Toward preventing Parkinson's diseaseBrit Mollenhauer, Christine A F von ArnimBrain : a Journal of Neurology|July 26, 2022
CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathologyShay Herman, Ruth Djaldetti, Brit Mollenhauer, et al.Pageof 53